Especiales Tecnociencia  
Octubre 2003
Especial sobre la gripe

BIBLIOGRAFÍA MEDLINE

  • Severe morbidity and mortality associated with influenza in children and young adults--Michigan, 2003.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep. 2003 Sep 5;52(35):837-40.

  • Summaries for patients. Cost-effective management of flu in adults older than 65 years of age.
    Ann Intern Med. 2003 Sep 2;139(5 Pt 1):I27.
     
  • Management of influenza in adults older than 65 years of age: cost-effectiveness of rapid testing and antiviral therapy.
    Rothberg MB, Bellantonio S, Rose DN.
    Ann Intern Med. 2003 Sep 2;139(5 Pt 1):321-9. Summary for patients in: Ann Intern Med. 2003 Sep 2;139(5 Pt 1):I27.

  • An advisory committee statement (ACS). National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 2003-2004 season.
    National Advisory Committee on Immunization.
    Can Commun Dis Rep. 2003 Aug 15;29:1-20.

  • Compromised constitutions: the Iranian experience with the 1918 influenza pandemic.
    Afkhami A.
    Bull Hist Med. 2003 Summer;77(2):367-92.

  • Harmonisation of national influenza surveillance morbidity data from EISS: a simple index.
    Uphoff H, Cohen JM, Fleming D, Noone A.
    Euro Surveill. 2003 Jul;8(7):156-64.

  • Epidemiology and control of influenza.
    Rao BL.
    Natl Med J India. 2003 May-Jun;16(3):143-9.
     
  • Annual report of the National Influenza Surveillance Scheme, 2002.
    Yohannes K, Roche P, Spencer J, Hampson A.
    Commun Dis Intell. 2003;27(2):162-72.

  • Economic evaluation of influenza vaccination in Thai chronic obstructive pulmonary disease patients.
    Wongsurakiat P, Lertakyamanee J, Maranetra KN, Jongriratanakul S, Sangkaew S.
    J Med Assoc Thai. 2003 Jun;86(6):497-508.

  • Poor uptake of influenza vaccinations in patients receiving cytotoxic chemotherapy.
    Ring A, Marx G, Steer C, Prendiville J, Ellis P.
    Int J Clin Pract. 2003 Jul-Aug;57(6):542-3.

  • Kassianos G.
    Influenza vaccination of patients receiving cytotoxic chemotherapy: can we do better?
    Int J Clin Pract. 2003 Jul-Aug;57(6):457-8.

  • Neuraminidase inhibitors for preventing and treating influenza in children.
    Matheson NJ, Symmonds-Abrahams M, Sheikh A, Shepperd S, Harnden A.
    Cochrane Database Syst Rev. 2003;(3):CD002744.
     
  • Invited commentary: Use of selective viral cultures to adjust nonvirologic endpoints in studies of influenza vaccine efficacy.
    Monto AS.
    Am J Epidemiol. 2003 Aug 15;158(4):312-5.

  • Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A (H1N1) and B using surveillance cultures.
    Halloran ME, Longini IM Jr, Gaglani MJ, Piedra PA, Chu H, Herschler GB, Glezen WP.
    Am J Epidemiol. 2003 Aug 15;158(4):305-11.

  • Hong Kong under WHO spotlight after flu outbreak.
    Parry J.
    BMJ. 2003 Aug 9;327(7410):308.

  • Quantification of the influenza virus load by real-time polymerase chain reaction in nasopharyngeal swabs of patients treated with oseltamivir.
    Boivin G, Coulombe Z, Wat C.
    J Infect Dis. 2003 Aug 15;188(4):578-80. Epub 2003 Aug 05.

  • Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: results of a randomized, prospective, controlled trial.
    Bonner AB, Monroe KW, Talley LI, Klasner AE, Kimberlin DW.
    Pediatrics. 2003 Aug;112(2):363-7.

  • Farmers kill 23 million birds to stop influenza virus.
    Crabb C.
    Bull World Health Organ. 2003;81(6):471. Epub 2003 Jul 25.

  • Clinical features of influenza a virus infection in older hospitalized persons.
    Drinka PJ, Krause P, Nest L.
    J Am Geriatr Soc. 2003 Aug;51(8):1184.

  • Three years of low influenza activity--no reason for complacency.
    Goddard NL, Joseph CA, Watson JM, Ellis JS, Zambon MC.
    Commun Dis Public Health. 2003 Jun;6(2):128-32.

  • Review of the use of neuraminidase inhibitors for prophylaxis of influenza.
    Kirkbride HA, Watson J.
    Commun Dis Public Health. 2003 Jun;6(2):123-7.

  • Clinical characteristics of children with influenza A virus infection requiring hospitalization.
    Wang YH, Huang YC, Chang LY, Kao HT, Lin PY, Huang CG, Lin TY.
    J Microbiol Immunol Infect. 2003 Jun;36(2):111-6.

  • Prevalence of viral myocarditis.
    Cheng TO.
    Arch Intern Med. 2003 Jul 28;163(14):1742.

  • Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations.
    Kaiser L, Wat C, Mills T, Mahoney P, Ward P, Hayden F.
    Arch Intern Med. 2003 Jul 28;163(14):1667-72.

  • Influenza outbreak related to air travel.
    Marsden AG.
    Med J Aust. 2003 Aug 4;179(3):172-3.

  • Influenza vaccination in Europe: an inventory of strategies to reach target populations and optimise vaccination uptake.
    Kroneman M, Paget WJ, van Essen GA.
    Euro Surveill. 2003 Jun;8(6):130-8.

  • Influenza B acute necrotizing encephalopathy: a case report and literature review.
    Sazgar M, Robinson JL, Chan AK, Sinclair DB.
    Pediatr Neurol. 2003 May;28(5):396-9.

  • A randomized controlled trial comparing split and subunit influenza vaccines in adults in Colombia.
    Morales A, Arias Salazar J, Salazar Y, Garcia A, Arnoux S, Arancibia A, Deroche C, Rey E.
    Medicina (B Aires). 2003;63(3):197-204.

  • Radiographic and high-resolution CT findings of influenza virus pneumonia in patients with hematologic malignancies.
    Oikonomou A, Muller NL, Nantel S.
    AJR Am J Roentgenol. 2003 Aug;181(2):507-11.

  • Comparison of symptoms of influenza A with abacavir-associated hypersensitivity reaction.
    Keiser P, Nassar N, Skiest D, Andrews C, Yazdani B, White A, Hetherington S.
    Int J STD AIDS. 2003 Jul;14(7):478-81.

  • Lyme disease presenting as an influenza-like illness.
    Porwancher R.
    Am J Med. 2003 Jul;115(1):73; author reply 73-4.

  • Study confirms multiple benefits of influenza vaccination.
    Rollins G.
    Rep Med Guidel Outcomes Res. 2003 May 2;14(9):7-9.

  • Virus-neutralizing activity mediated by the Fab fragment of a hemagglutinin-specific antibody is sufficient for the resolution of influenza virus infection in SCID mice.
    Mozdzanowska K, Feng J, Gerhard W.
    J Virol. 2003 Aug;77(15):8322-8.

  • Winter respiratory viruses and health care use: a population-based study in the northwest United States.
    Neuzil KM, Maynard C, Griffin MR, Heagerty P.
    Clin Infect Dis. 2003 Jul 15;37(2):201-7. Epub 2003 Jul 07.

  • Neuraminidase inhibitors for influenza A and B: PROSE may be as useful as POEMs.
    Bradley NC.
    BMJ. 2003 Jul 12;327(7406):105.

  • Neuraminidase inhibitors for influenza A and B: antivirals need to be protected from adverse conditions to retain effectiveness.
    Arya SC, Agarwal N.
    BMJ. 2003 Jul 12;327(7406):105-6.

  • Neuraminidase inhibitors for influenza A and B: study showed benefits of treatment are marginal.
    Oliver M.
    BMJ. 2003 Jul 12;327(7406):105.

  • Avian influenza.
    Johnston M.
    J R Soc Health. 2003 Jun;123(2):80.

  • Suboptimal detection of influenza virus in adults by the Directigen Flu A+B enzyme immunoassay and correlation of results with the number of antigen-positive cells detected by cytospin immunofluorescence.
    Landry ML, Ferguson D.
    J Clin Microbiol. 2003 Jul;41(7):3407-9.

  • Pathogenic and antigenic properties of phylogenetically distinct reassortant H3N2 swine influenza viruses cocirculating in the United States.
    Richt JA, Lager KM, Janke BH, Woods RD, Webster RG, Webby RJ.
    J Clin Microbiol. 2003 Jul;41(7):3198-205.

  • Influenza as a bioweapon.
    Madjid M, Lillibridge S, Mirhaji P, Casscells W.
    J R Soc Med. 2003 Jul;96(7):345-6.

  • Generation of influenza A viruses with chimeric (type A/B) hemagglutinins.
    Horimoto T, Takada A, Iwatsuki-Horimoto K, Hatta M, Goto H, Kawaoka Y.
    J Virol. 2003 Jul;77(14):8031-8.

  • A rare appearance of influenza A(H1N2) as a reassortant in a community such as Yamagata where A(H1N1) and A(H3N2) co-circulate.
    Mizuta K, Katsushima N, Ito S, Sanjoh K, Murata T, Abiko C, Murayama S.
    Microbiol Immunol. 2003;47(5):359-61.

  • Epidemiology and molecular characterization of co-circulating influenza A/H3N2 virus variants in children: Houston, Texas, 1997-8.
    O'Donnell FT, Munoz FM, Atmar RL, Hwang LY, Demmler GJ, Glezen WP.
    Epidemiol Infect. 2003 Jun;130(3):521-31.

  • Oseltamivir: new preparation. An antiviral agent with little impact on influenza.
    Prescrire Int. 2003 Jun;12(65):85-8.
  • High frequency of resistant viruses harboring different mutations in amantadine-treated children with influenza.
    Shiraishi K, Mitamura K, Sakai-Tagawa Y, Goto H, Sugaya N, Kawaoka Y.
    J Infect Dis. 2003 Jul 1;188(1):57-61. Epub 2003 Jun 23.

  • Recommendations pertaining to the use of viral vaccines: influenza. Review of influenza activity--2002.
    National Institute for Communicable Diseases.
    S Afr Med J. 2003 Apr;93(4):271.

  • Influenza vaccination in old adults in Spain.
    Sarria-Santamera A, Timoner J.
    Eur J Public Health. 2003 Jun;13(2):133-7.

  • Update: influenza activity--United States and worldwide, 2002-03 season, and composition of the 2003-04 influenza vaccine.
    MMWR Morb Mortal Wkly Rep. 2003 Jun 6;52(22):516-21.

  • Febrile respiratory tract illness in a 3-month old infant.
    Munoz FM.
    Paediatr Respir Rev. 2003 Jun;4(2):162-3.

  • Vaccination for pandemic influenza and severe acute respiratory syndrome: common issues and concerns.
    Fedson DS.
    Clin Infect Dis. 2003 Jun 15;36(12):1562-3. Epub 2003 Jun 05.

  • Pandemic influenza and the global vaccine supply.
    Fedson DS.
    Clin Infect Dis. 2003 Jun 15;36(12):1552-61. Epub 2003 Jun 05.

  • Influenza.
    Olshaker JS.
    Emerg Med Clin North Am. 2003 May;21(2):353-61.

  • Attitudes of pediatricians regarding influenza self-immunization: a survey in a Swiss university children's hospital.
    Heininger U, Bachler M, Schaad UB.
    Pediatr Infect Dis J. 2003 May;22(5):391-4.

  • Use of ambulance dispatch data as an early warning system for communitywide influenzalike illness, New York City.
    Mostashari F, Fine A, Das D, Adams J, Layton M.
    J Urban Health. 2003 Jun;80(2 Suppl 1):i43-9.

  • We need to determine who benefits most from flu treatments.
    Hansen L.
    BMJ. 2003 Jun 7;326(7401):1239-40.

  • Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials.
    Cooper NJ, Sutton AJ, Abrams KR, Wailoo A, Turner D, Nicholson KG.
    BMJ. 2003 Jun 7;326(7401):1235.

  • Preventing and treating influenza.
    Stohr K.
    BMJ. 2003 Jun 7;326(7401):1223-4.

  • Replication and transmission of influenza viruses in Japanese quail.
    Makarova NV, Ozaki H, Kida H, Webster RG, Perez DR.
    Virology. 2003 May 25;310(1):8-15.

  • Traveling waves in a model of influenza A drift.
    Lin J, Andreasen V, Casagrandi R, Levin SA.
    J Theor Biol. 2003 Jun 21;222(4):437-45.

  • The influenza and other epidemics. Med J Aust 1919;1:71-72.
    MacLaurin C.
    Med J Aust. 2003 May 19;178(10):511.

  • Characterization of H9 subtype influenza viruses from the ducks of southern China: a candidate for the next influenza pandemic in humans?
    Li KS, Xu KM, Peiris JS, Poon LL, Yu KZ, Yuen KY, Shortridge KF, Webster RG, Guan Y.
    J Virol. 2003 Jun;77(12):6988-94.

  • Molecular characterization of influenza B viruses circulating in northern Italy during the 2001-2002 epidemic season.
    Ansaldi F, D'Agaro P, De Florentiis D, Puzelli S, Lin YP, Gregory V, Bennett M, Donatelli I, Gasparini R, Crovari P, Hay A, Campello C.
    J Med Virol. 2003 Jul;70(3):463-9.

  • Effect of a rapid influenza diagnosis.
    Esposito S, Marchisio P, Morelli P, Crovari P, Principi N.
    Arch Dis Child. 2003 Jun;88(6):525-6.

  • Antimicrobial resistance in Haemophilus influenzae and Moraxella catarrhalis respiratory tract isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002.
    Zhanel GG, Palatnick L, Nichol KA, Low DE, Hoban DJ; CROSS Study Group.
    Antimicrob Agents Chemother. 2003 Jun;47(6):1875-81.

  • Estimating deaths due to influenza and respiratory syncytial virus.
    Glezen WP, Couch RB.
    JAMA. 2003 May 21;289(19):2500; author reply 2500-2.

  • Estimating deaths due to influenza and respiratory syncytial virus.
    Simonsen L, Blackwelder WC, Reichert TA, Miller MA.
    JAMA. 2003 May 21;289(19):2499-500; author reply 2500-2.

  • Estimating deaths due to influenza and respiratory syncytial virus.
    Gay NJ, Andrews NJ, Trotter CL, Edmunds WJ.
    JAMA. 2003 May 21;289(19):2499; author reply 2500-2.

  • X-ray structure of the hemagglutinin of a potential H3 avian progenitor of the 1968 Hong Kong pandemic influenza virus.
    Ha Y, Stevens DJ, Skehel JJ, Wiley DC.
    Virology. 2003 May 10;309(2):209-18.

  • Influenza virus infection in infancy and early childhood.
    Munoz FM.
    Paediatr Respir Rev. 2003 Jun;4(2):99-104.

  • Influenza- and respiratory syncytial virus-associated morbidity and mortality in the nursing home population.
    Ellis SE, Coffey CS, Mitchel EF Jr, Dittus RS, Griffin MR.
    J Am Geriatr Soc. 2003 Jun;51(6):761-7.

  • [Low prevalence of flu vaccine in nonagenarians patients]
    Formiga F, Lopez Soto A, Masanes F, Pujol R.
    Med Clin (Barc). 2003 Jun 21;121(3):117-8.

  • Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Bridges CB, Harper SA, Fukuda K, Uyeki TM, Cox NJ, Singleton JA; Advisory Committee on Immunization Practices.
    MMWR Recomm Rep. 2003 Apr 25;52(RR-8):1-34; quiz CE1-4. Erratum in: MMWR Morb Mortal Wkly Rep. 2003 Jun 6;52(22):526.

  • Prenatal exposure to influenza as a risk factor for adult schizophrenia.
    Limosin F, Rouillon F, Payan C, Cohen JM, Strub N.
    Acta Psychiatr Scand. 2003 May;107(5):331-5.

  • Occurrence of influenza B/Hong Kong-like strains in Brazil, during 2002.
    de Paiva TM, Ishida MA, Goncalves MG, Benega MA, de Souza MC, Cruz AS.
    Rev Inst Med Trop Sao Paulo. 2003 Jan-Feb;45(1):51-2.

  • Increasing immunization rates among African-American adults.
    Adult Immunization Censensus Panel.
    J Natl Med Assoc. 2003 Apr;95(4 Suppl):37S-48S.

     
  • The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients.
    Cavdar C, Sayan M, Sifil A, Artuk C, Yilmaz N, Bahar H, Camsari T.
    Scand J Urol Nephrol. 2003;37(1):71-6.

  • Influenza vaccination in community-dwelling elderly: impact on mortality and influenza-associated morbidity.
    Voordouw BC, van der Linden PD, Simonian S, van der Lei J, Sturkenboom MC, Stricker BH.
    Arch Intern Med. 2003 May 12;163(9):1089-94.

  • Detection of influenza virus from throat and pharyngeal swabs with a nested duplex light cycler RT-PCR.
    Koenig M, Kosha S, Hickman M, Heath D, Riddell S, Aldous W.
    Diagn Microbiol Infect Dis. 2003 May;46(1):35-7.

  • Zanamivir in the treatment of influenza.
    Fleming DM.
    Expert Opin Pharmacother. 2003 May;4(5):799-805.

  • Pandemic influenza and healthcare demand in the Netherlands: scenario analysis.
    van Genugten ML, Heijnen ML, Jager JC.
    Emerg Infect Dis. 2003 May;9(5):531-8.

  • A large outbreak of influenza A and B on a cruise ship causing widespread morbidity.
    Brotherton JM, Delpech VC, Gilbert GL, Hatzi S, Paraskevopoulos PD, McAnulty JM; Cruise Ship Outbreak Investigation Team.
    Epidemiol Infect. 2003 Apr;130(2):263-71.

  • Vet dies from pneumonia in avian flu case.
    Sheldon T.
    BMJ. 2003 May 3;326(7396):952.

     
  • Dutch veterinarian becomes first victim of avian influenza.
    van Kolfschooten F.
    Lancet. 2003 Apr 26;361(9367):1444.

  • Shortage of influenza vaccine in 2000-2001: did it change patient beliefs?
    Zimmerman RK, Nowalk MP, Santibanez TA, Jewell IK, Raymond M.
    Am J Prev Med. 2003 May;24(4):349-53.

  • Pathology of human influenza A (H5N1) virus infection in cynomolgus macaques (Macaca fascicularis).
    Kuiken T, Rimmelzwaan GF, Van Amerongen G, Osterhaus AD.
    Vet Pathol. 2003 May;40(3):304-10.

  • CDC: annual flu deaths higher than previously estimated.
    FDA Consum. 2003 Mar-Apr;37(2):8.

  • [Encephalitis due to influenza A virus]
    Hernandez Gonzalez N, del Castillo Martin F, Suso Martinez de Bujo B.
    An Pediatr (Barc). 2003 Apr;58(4):397-8. Spanish.

  • [Heading for systematic flu vaccination?]
    Ortiz de Lejarazu R, Eiros JM.
    Med Clin (Barc). 2003 Mar 15;120(9):340-1.

  • Large summertime influenza A outbreak among tourists in Alaska and the Yukon Territory.
    Uyeki TM, Zane SB, Bodnar UR, Fielding KL, Buxton JA, Miller JM, Beller M, Butler JC, Fukuda K, Maloney SA, Cetron MS; Alaska/Yukon Territory Respiratory Outbreak Investigation Team.
    Clin Infect Dis. 2003 May 1;36(9):1095-102. Epub 2003 Apr 22.

  • Pharmacokinetics and delivery of the anti-influenza prodrug oseltamivir to the small intestine and colon using site-specific delivery capsules.
    Oo C, Snell P, Barrett J, Dorr A, Liu B, Wilding I.
    Int J Pharm. 2003 May 12;257(1-2):297-9.

  • Influenza outbreak in the district of Bosobolo, Democratic Republic of the Congo, November-December 2002.
    Wkly Epidemiol Rec. 2003 Mar 28;78(13):94-6.

  • Conventional influenza vaccination is not associated with complications in working-age patients with asthma or chronic obstructive pulmonary disease.
    Hak E, Hoes AW, Grobbee DE, Lammers JW, van Essen GA, van Loon AM, Verheij TJ.
    Am J Epidemiol. 2003 Apr 15;157(8):692-700.

  • Immunostimulatory activity of aminoalkyl glucosaminide 4-phosphates (AGPs): induction of protective innate immune responses by RC-524 and RC-529.
    Baldridge JR, Cluff CW, Evans JT, Lacy MJ, Stephens JR, Brookshire VG, Wang R, Ward JR, Yorgensen YM, Persing DH, Johnson DA.
    J Endotoxin Res. 2002;8(6):453-8.

  • Lack of detection of influenza genes in archived formalin-fixed, paraffin wax-embedded brain samples of encephalitis lethargica patients from 1916 to 1920.
    Lo KC, Geddes JF, Daniels RS, Oxford JS.
    Virchows Arch. 2003 Jun;442(6):591-6. Epub 2003 Apr 15.

  • Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors.
    Oxford JS, Bossuyt S, Balasingam S, Mann A, Novelli P, Lambkin R.
    Clin Microbiol Infect. 2003 Jan;9(1):1-14.

  • Influenza A-associated central nervous system dysfunction in children presenting as transient visual hallucination.
    Huang YC, Lin TY, Wu SL, Tsao KC.
    Pediatr Infect Dis J. 2003 Apr;22(4):366-8.

  • Cerebrospinal fluid and serum levels of cytokines and soluble tumor necrosis factor receptor in influenza virus-associated encephalopathy.
    Ichiyama T, Isumi H, Ozawa H, Matsubara T, Morishima T, Furukawa S.
    Scand J Infect Dis. 2003;35(1):59-61.

  • Zanamivir: a significant reduction in viral load during treatment in military conscripts with influenza.
    Puhakka T, Lehti H, Vainionpaa R, Jormanainen V, Pulkkinen M, Sharp S, Kerr C, Dempsey M, Ring CJ, Ward C, Tisdale M.
    Scand J Infect Dis. 2003;35(1):52-8.

  • Treatment and prevention of influenza: Swedish recommendations.
    Uhnoo I, Linde A, Pauksens K, Lindberg A, Eriksson M, Norrby R; Swedish Consensus Group.
    Scand J Infect Dis. 2003;35(1):3-11.

  • Compared protective effect of nasal immunoprophylaxis using a new human monoclonal IgM antibody, human polyclonal antibodies, F(ab')2, amantadine, and zanamivir for prophylaxis of influenza A virus pneumonia in mice.
    Hernandez E, Ramisse F, Lhonneux A, Noury J, Bazin H, Cavallo JD.
    Mil Med. 2003 Mar;168(3):246-51.

  • The next influenza pandemic: lessons from Hong Kong.
    Shortridge KF, Peiris JS, Guan Y.
    J Appl Microbiol. 2003;94 Suppl:70S-79S.

  • Influenza fact sheet.
    Wkly Epidemiol Rec. 2003 Mar 14;78(11):77-80.

  • Looming flu pandemic has experts crying fowl.
    Clayton J.
    Nat Med. 2003 Apr;9(4):375.

  • Prescription of neuraminidase inhibitors for influenza.
    Madeley D.
    J R Soc Med. 2003 Apr;96(4):207-8.

  • Evaluation of a rapid test (QuickVue) compared with the shell vial assay for detection of influenza virus clearance after antiviral treatment.
    Bellei N, Benfica D, Perosa AH, Carlucci R, Barros M, Granato C.
    J Virol Methods. 2003 Apr;109(1):85-8.

  • A double-blind, randomized, placebo-controlled multicenter study of oseltamivir phosphate for treatment of influenza infection in China.
    Li L, Cai B, Wang M, Zhu Y.
    Chin Med J (Engl). 2003 Jan;116(1):44-8.

  • Rapid antigen testing for the surveillance of influenza epidemics.
    Wunderli W, Thomas Y, Muller DA, Dick M, Kaiser L.
    Clin Microbiol Infect. 2003 Apr;9(4):295-300.

  • Economic analysis of influenza vaccination and treatment.
    Meltzer MI, Bridges CB.
    Ann Intern Med. 2003 Apr 1;138(7):608; author reply 608-9.

  • Economic analysis of influenza vaccination and treatment.
    Gandjour A.
    Ann Intern Med. 2003 Apr 1;138(7):607-8; author reply 608-9.

  • Economic analysis of influenza vaccination and treatment.
    Brodkin H.
    Ann Intern Med. 2003 Apr 1;138(7):607; author reply 608-9.

  • Economic analysis of influenza vaccination and treatment.
    Jefferson T, Demicheli V.
    Ann Intern Med. 2003 Apr 1;138(7):607; author reply 608-9.

  • Influenza in Canada: 2001-2002 season.
    Macey JF, Tam TW, Li Y, Winchester B, Zabchuk P.
    Can Commun Dis Rep. 2003 Mar 15;29(6):45-59.

  • Recommended composition of influenza virus vaccines for use in the 2003-2004 influenza season.
    Wkly Epidemiol Rec. 2003 Feb 28;78(9):58-62.

  • Update: Influenza activity--United States, 2002-03 season.
    MMWR Morb Mortal Wkly Rep. 2003 Mar 21;52(11):224-5.

  • Acceptability and uptake of a community-based flu immunisation programme.
    Farmer J, Iversen L, Peterkin G, Strachan P, Kelman H, Proctor K, Emslie M.
    Health Bull (Edinb). 2001 Mar;59(2):127-35.

  • Human infection by a swine influenza A (H1N1) virus in Switzerland.
    Gregory V, Bennett M, Thomas Y, Kaiser L, Wunderli W, Matter H, Hay A, Lin YP.
    Arch Virol. 2003 Apr;148(4):793-802.

  • Ecological and immunological determinants of influenza evolution.
    Ferguson NM, Galvani AP, Bush RM.
    Nature. 2003 Mar 27;422(6930):428-33.

  • Syndromic analysis of computerized emergency department patients' chief complaints: an opportunity for bioterrorism and influenza surveillance.
    Irvin CB, Nouhan PP, Rice K.
    Ann Emerg Med. 2003 Apr;41(4):447-52.

  • Influenza vaccine in chronic lymphoproliferative disorders and multiple myeloma.
    Rapezzi D, Sticchi L, Racchi O, Mangerini R, Ferraris AM, Gaetani GF.
    Eur J Haematol. 2003 Apr;70(4):225-30.

  • Encephalitis associated with influenza B virus infection in 2 children and a review of the literature.
    Newland JG, Romero JR, Varman M, Drake C, Holst A, Safranek T, Subbarao K.
    Clin Infect Dis. 2003 Apr 1;36(7):e87-95. Epub 2003 Mar 20.

  • Influenza.
    Wkly Epidemiol Rec. 2003 Feb 7;78(6):39-40.